Top Stories
Zhejiang Geely Completes Acquisition Of Ford's Volvo Car Corp - Quick Facts 1020 days ago
Mindspeed's Comcerto 300xv Processor Cuts Fiber-Access Equipment Costs And Power Consumption For VoIP Service Delivery 1020 days ago
Magic Software Enterprises Q2 Profit Rises - Quick Facts 1020 days ago
British Land , Blackstone JV Signs Deal For Leases With UBS - Quick Facts 1020 days ago
Clearwire And City Of Grand Rapids Announce CLEAR 4G Internet Service For Western Michigan 1020 days agomore >>
What´s New Page
Top Gainers Stocks of the Day: NMTI, AMLN, ALKS, FSII
We daily monitor the following NASDAQ stocks :
NMT Medical, Inc. (NMTI) is a well-known name in the domain of medical technology. The company is involved in manufacturing, developing, designing proprietary implant technologies related to the market. Thus, they help the cardiologists across the world in treating different structural ailments of the heart by means of procedures, which are invasive at the minimal rate are based on catheter applications. The company has announced the receipt of the results at the preliminary level for the Closure I. The patent to be released will be a clinical trial to prove the effectiveness of PFO treatment towards preventing the recurrent rate of strokes. The last sale value of the stock has been 0.75. The stock is up by 33.93% and the change is market at 0.19. The range of High and Low has been 0.8399-0.6199. The stock was at 0.56 and opened at 0.68 today. The 52-week high and Low has been 4.99-0.52.
Amylin Pharmaceuticals, Inc. (AMLN) is a company dealing in biopharmaceutical products. The company is dedicatedly working towards improvement of the lives of the patients. This is done by means of developing, discovering and commercializing the innovative medicines. The company has reported that they have presented the data for the drug SYMLIN (pramlintide acetate) and BYETTA (exenatide) injection approved by FDA for the treatment of diabetes. The AMLN stock opened closed yesterday at 16.51 and opened today at 18.85. The last sale has been 19.00 and it is up (+2.49 +15.08%). The High and the Low for the Day stood at 19.51 -18.74. The volume has been 8.81 Mil. The 52-week High and Low has been at 24.21 and 11.01 respectively.. The Average Daily Volume over the 13 weeks is at 2.92 Mil.
Alkermes, Inc. (ALKS) is a biotechnology company, which is fully integrated towards the commitment to develop a range of innovative medicine and bring a spell of improvement in the life of the patient. VIVITROL(R) is a medicine manufactured and commercialized by Alkermes in order to prevent the dependence on alcohol. Another great product is RISPERDAL(R) CONSTA(R) to treat diseases like bipolar I disorder and schizophrenia. Yesterday it has been declared by the company that FDA has notified them for scheduling a meeting for Psychopharmacologic Drugs Advisory Committee on 16th September, 2010. The stock has been at 11.56 during the close of the previous day. The last sale price has been 12.41. It is moving upwards at (0.85 +7.35%). The stock opened at 12.00. The daily high and low has been 12.80 and 12.00. The volume of trade has been 1.77 Mil. The average daily volume over a span of 13 weeks is 960,272. The 52-week high and low has been 14.19- 7.54.
FSI International, Inc. (FSII)is a company, which can be considered as a global supplier providing equipments for surface conditioning and also offering support in the technological field. For the industry dealing on manufacturing of microelectronics. The company will release its Q3 financial report for the fiscal year 2010 on June 24, Thursday, 2010. The previous day’s close of the FSII stock was 4.50. The stock opened at 4.53. The last sale price has been 4.81, which is up by (+0.31 +6.89%). The Daily high and low has been at 4.83 and 4.53. The volume of trade has been 1.43 Mil. The average daily volume over the 13 weeks has been 653,327. The 52 Week High 4.56 stood at 4.56 and the 52-week low is at 0.3.
To Subscribe to these free Stock Newsletters visit: http://theotcmarket.com.
TheOTCmarket.com provides independent, unbiased and a comprehensive overview of any new development and trends in the investor and financial market.
ABOUT : http://theotcmarket.com/
TheOTCmarket offers Stock Newsletter on various hot stocks of the day.
We publish daily news in the form of our Market Snapshot and also provide daily Hot Stocks for its visitors. Additional attractions for investors and financial institutions are offered in the form of stock alerts, newsletters and other forms of subscribed information.
You can become leader in stock market by keeping track of the daily activity.
Disclaimer:
THEOTCM electronically disseminates information (the “Information”) on its websites, in newsletters, featured reports, spam compliant double-opt in email communications or otherwise pertaining to Featured Stocks’ (the “Issuer” or “Issuers” or “Featured Stock” or “Featured Stocks”), the securities of which are most frequently common stock shares quoted on the Over the Counter Bulletin Board (“OTCBB”) or Pink Sheets. The Information is based on publicly available information, such as quarterly (with unaudited financial statements) and annual reports (with audited financial statements) filed with the Securities and Exchange Commission (“SEC”), quarterly and annual unaudited financial reports and Information and Disclosure Statements filed with the Pink Sheets, the Issuer’s website and information obtained through search engines such as Yahoo Finance, Market Watch, PRnewswire, StockHouse, StockWatch, OTCmarket and Business Wire. We synthesize the Information from these informational sources for our Readers as a starting point for further inquiry into the Issuer and its securities.
Post Comments
By bwcolemen on Top OTC Stocks Gainers | Friday June 18, 2010 02:56 pm
TheOTCMarket.com is an investor-oriented resource centre offering relevant news and information vital to investors in the financial sector. We provide as well Free Penny Stock Alerts at theOTCmarket.comWe daily monitor the following NASDAQ stocks :
NMT Medical, Inc. (NMTI) is a well-known name in the domain of medical technology. The company is involved in manufacturing, developing, designing proprietary implant technologies related to the market. Thus, they help the cardiologists across the world in treating different structural ailments of the heart by means of procedures, which are invasive at the minimal rate are based on catheter applications. The company has announced the receipt of the results at the preliminary level for the Closure I. The patent to be released will be a clinical trial to prove the effectiveness of PFO treatment towards preventing the recurrent rate of strokes. The last sale value of the stock has been 0.75. The stock is up by 33.93% and the change is market at 0.19. The range of High and Low has been 0.8399-0.6199. The stock was at 0.56 and opened at 0.68 today. The 52-week high and Low has been 4.99-0.52.
Amylin Pharmaceuticals, Inc. (AMLN) is a company dealing in biopharmaceutical products. The company is dedicatedly working towards improvement of the lives of the patients. This is done by means of developing, discovering and commercializing the innovative medicines. The company has reported that they have presented the data for the drug SYMLIN (pramlintide acetate) and BYETTA (exenatide) injection approved by FDA for the treatment of diabetes. The AMLN stock opened closed yesterday at 16.51 and opened today at 18.85. The last sale has been 19.00 and it is up (+2.49 +15.08%). The High and the Low for the Day stood at 19.51 -18.74. The volume has been 8.81 Mil. The 52-week High and Low has been at 24.21 and 11.01 respectively.. The Average Daily Volume over the 13 weeks is at 2.92 Mil.
Alkermes, Inc. (ALKS) is a biotechnology company, which is fully integrated towards the commitment to develop a range of innovative medicine and bring a spell of improvement in the life of the patient. VIVITROL(R) is a medicine manufactured and commercialized by Alkermes in order to prevent the dependence on alcohol. Another great product is RISPERDAL(R) CONSTA(R) to treat diseases like bipolar I disorder and schizophrenia. Yesterday it has been declared by the company that FDA has notified them for scheduling a meeting for Psychopharmacologic Drugs Advisory Committee on 16th September, 2010. The stock has been at 11.56 during the close of the previous day. The last sale price has been 12.41. It is moving upwards at (0.85 +7.35%). The stock opened at 12.00. The daily high and low has been 12.80 and 12.00. The volume of trade has been 1.77 Mil. The average daily volume over a span of 13 weeks is 960,272. The 52-week high and low has been 14.19- 7.54.
FSI International, Inc. (FSII)is a company, which can be considered as a global supplier providing equipments for surface conditioning and also offering support in the technological field. For the industry dealing on manufacturing of microelectronics. The company will release its Q3 financial report for the fiscal year 2010 on June 24, Thursday, 2010. The previous day’s close of the FSII stock was 4.50. The stock opened at 4.53. The last sale price has been 4.81, which is up by (+0.31 +6.89%). The Daily high and low has been at 4.83 and 4.53. The volume of trade has been 1.43 Mil. The average daily volume over the 13 weeks has been 653,327. The 52 Week High 4.56 stood at 4.56 and the 52-week low is at 0.3.
To Subscribe to these free Stock Newsletters visit: http://theotcmarket.com.
TheOTCmarket.com provides independent, unbiased and a comprehensive overview of any new development and trends in the investor and financial market.
ABOUT : http://theotcmarket.com/
TheOTCmarket offers Stock Newsletter on various hot stocks of the day.
We publish daily news in the form of our Market Snapshot and also provide daily Hot Stocks for its visitors. Additional attractions for investors and financial institutions are offered in the form of stock alerts, newsletters and other forms of subscribed information.
You can become leader in stock market by keeping track of the daily activity.
Disclaimer:
THEOTCM electronically disseminates information (the “Information”) on its websites, in newsletters, featured reports, spam compliant double-opt in email communications or otherwise pertaining to Featured Stocks’ (the “Issuer” or “Issuers” or “Featured Stock” or “Featured Stocks”), the securities of which are most frequently common stock shares quoted on the Over the Counter Bulletin Board (“OTCBB”) or Pink Sheets. The Information is based on publicly available information, such as quarterly (with unaudited financial statements) and annual reports (with audited financial statements) filed with the Securities and Exchange Commission (“SEC”), quarterly and annual unaudited financial reports and Information and Disclosure Statements filed with the Pink Sheets, the Issuer’s website and information obtained through search engines such as Yahoo Finance, Market Watch, PRnewswire, StockHouse, StockWatch, OTCmarket and Business Wire. We synthesize the Information from these informational sources for our Readers as a starting point for further inquiry into the Issuer and its securities.
Post Comments

- Pick of the Day ATNP and KENS
- BIEL, LIEG, EQLB Active OTC Stocks on Watch
- OTC Movers on Watch: ESPH, IFTI, SBRH
- Morning OTC Stocks Top Volume Leaders: ZVTK, GERS, PTSH
- Morning OTC Stocks Top Gainers of the Day: MTVO, SECI, BGOI
- OTC Stocks Gainers of the Day: WOLV, SECI, BSGC
- Top OTC Stocks Gainers of the Day: VASO, ECOB, GNOLF, CTDBQ
- OTC Stocks Top Gainers: PSWS, CEMI, ERFW, CTDBD
- May 20th Top OTC Stocks Gainers: NTRO, JUNP, CCTR, RMLX


